Nearly Cured of Type 1 Diabetes: One Woman’s Journey in the Eledon Trial
Send us Fan Mail
In this week's very special episode of the Diabetes Nerd Podcast, we chat with Katie Beth Hand, who shares her experience with the Elodon clinical trial.
Katie Beth is a participant in Eledon Pharmaceuticals' clinical trial using an ANTI-CD40L therapy known as tegoprubart. This groundbreaking therapy is a very targeted immunosuppressant that blocks a specific signal in the immune system, rather than suppressing your entire immune system.
One month ago, Katie received a transfusion to implant cadaver islet cells. Today, she's only taking a few units of rapid-acting insulin…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.